Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
Titel:
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
Auteur:
Heppner Jr, D Gray Kemp, Tracy L Martin, Brian K Ramsey, William J Nichols, Richard Dasen, Emily J Link, Charles J Das, Rituparna Xu, Zhi Jin Sheldon, Eric A Nowak, Teresa A Monath, Thomas P